Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Athena Diagnostics | RCV001288460 | SCV001475578 | likely pathogenic | not provided | 2020-02-18 | criteria provided, single submitter | clinical testing | The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Not found in the total gnomAD dataset, and the data is high quality. |
Labcorp Genetics |
RCV001871714 | SCV002216082 | pathogenic | Ataxia-telangiectasia syndrome | 2021-08-27 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 994786). This premature translational stop signal has been observed in individual(s) with Ataxia-telangiectasia (PMID: 21665257, 27664052). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Phe2958*) in the ATM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ATM are known to be pathogenic (PMID: 23807571, 25614872). |